Novus Therapeutics, Inc
4 clinical trials · Sponsor
◉ Watch Novus Therapeutics, Inc
| Record | Firm | Date |
|---|---|---|
| A Study to Assess the Safety, Tolerability and Efficacy of OP0201 as an Adjunct Treatment for Acute Otitis Media in Infants and Children Aged 6 to 24 Months (NCT03818815) | Novus Therapeutics, Inc | 2019-02-21 |
| Evaluation of Safety and Pharmacodynamics of OP0201 Compared to Placebo in Healthy Adults (NCT03828149) | Novus Therapeutics, Inc | 2019-02-08 |
| Evaluation of Safety and Reduction of Ear Pain in Adults With Acute Otitis Media and Reduction of Ear Pain in Adults With Acute Otitis Media (NCT03766373) | Novus Therapeutics, Inc | 2019-01-07 |
| Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers (NCT03748758) | Novus Therapeutics, Inc | 2018-11-27 |
Track Novus Therapeutics, Inc automatically
Every clearance here is in the API, with alerts when new ones post.